Gut Microbiota Dysbiosis in Diabetic Retinopathy—Current Knowledge and Future Therapeutic Targets

Diabetic retinopathy is one of the major causes of blindness today, despite important achievements in diagnosis and therapy. The involvement of a gut–retina axis is thought to be a possible risk factor for several chronic eye disease, such as glaucoma, age-related macular degeneration, uveitis, and, recently, diabetic retinopathy. Dysbiosis may cause endothelial disfunction and alter retinal metabolism. This review analyzes the evidence regarding changes in gut microbiota in patients with DR compared with diabetics and healthy controls (HCs). A systematic review was performed on PubMed, Web of Science, and Google Scholar for the following terms: “gut microbiota” OR “gut microbiome” AND “diabetic retinopathy”. Ultimately, 9 articles published between 2020 and 2022 presenting comparative data on a total of 228 T2DM patients with DR, 220 patients with T2DM, and 118 HCs were analyzed. All of the studies found a distinctive microbial beta diversity in DR vs. T2DM and HC, characterized by an altered Firmicutes/Bacteroidetes ratio, a decrease in butyrate producers, and an increase in LPS-expressing and pro-inflammatory species in the Bacteroidetes and Proteobacteria phyla. The probiotic species Bifidobacterium and Lactobacillus were decreased when compared with T2DM. Gut microbiota influence retinal health in multiple ways and may represent a future therapeutic target in DR.

[1]  G. Gerhard,et al.  Bile Acids Induce Neurite Outgrowth in Nsc-34 Cells via TGR5 and a Distinct Transcriptional Profile , 2023, Pharmaceuticals.

[2]  Weizhen Liu,et al.  Specific alterations of gut microbiota in diabetic microvascular complications: A systematic review and meta-analysis , 2022, Frontiers in Endocrinology.

[3]  Xudong Bai,et al.  The Gut–Eye Axis: Correlation Between the Gut Microbiota and Autoimmune Dry Eye in Individuals With Sjögren Syndrome , 2022, Eye & contact lens.

[4]  H. Tamaki,et al.  Bile Salt Hydrolases with Extended Substrate Specificity Confer a High Level of Resistance to Bile Toxicity on Atopobiaceae Bacteria , 2022, International journal of molecular sciences.

[5]  Daniel S. Kermany,et al.  Dysbiosis of gut microbiome contributes to glaucoma pathogenesis , 2022, MedComm – Future Medicine.

[6]  Yuanyuan Zhang,et al.  Composition and diversity of gut microbiota in diabetic retinopathy , 2022, Frontiers in Microbiology.

[7]  R. Yao,et al.  The role and mechanisms of gut microbiota in diabetic nephropathy, diabetic retinopathy and cardiovascular diseases , 2022, Frontiers in Microbiology.

[8]  Kaibo Yang,et al.  Metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in patients with type 2 diabetes , 2022, Frontiers in Immunology.

[9]  E. Oprea,et al.  Therapeutic Benefits and Dietary Restrictions of Fiber Intake: A State of the Art Review , 2022, Nutrients.

[10]  R. Kandimalla,et al.  Probiotics: Evolving as a Potential Therapeutic Option against Acetaminophen-Induced Hepatotoxicity , 2022, Biomedicines.

[11]  F. Bosco,et al.  The Contribution of Gut Microbiota and Endothelial Dysfunction in the Development of Arterial Hypertension in Animal Models and in Humans , 2022, International journal of molecular sciences.

[12]  Wenjing Zhang,et al.  Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus , 2022, Diabetes, metabolic syndrome and obesity : targets and therapy.

[13]  A. Minnella,et al.  Gut Microbiome in Retina Health: The Crucial Role of the Gut-Retina Axis , 2022, Frontiers in Microbiology.

[14]  M. Grant,et al.  Microbial Signatures in The Rodent Eyes With Retinal Dysfunction and Diabetic Retinopathy , 2022, Investigative ophthalmology & visual science.

[15]  Jinghua Jiao,et al.  Recent Insights into the Role of Gut Microbiota in Diabetic Retinopathy , 2021, Journal of inflammation research.

[16]  M. Rizzo,et al.  Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic Targets , 2021, The International Journal of Lower Extremity Wounds.

[17]  Ting-Ting Chang,et al.  Direct CCL4 Inhibition Modulates Gut Microbiota, Reduces Circulating Trimethylamine N-Oxide, and Improves Glucose and Lipid Metabolism in High-Fat-Diet-Induced Diabetes Mellitus , 2021, Journal of inflammation research.

[18]  Xiaojing Xiong,et al.  Gut Microbiota Composition and Fecal Metabolic Profiling in Patients With Diabetic Retinopathy , 2021, Frontiers in Cell and Developmental Biology.

[19]  A. Cherecheanu,et al.  Outcomes of Diabetic Retinopathy Post-Bariatric Surgery in Patients with Type 2 Diabetes Mellitus , 2021, Journal of clinical medicine.

[20]  D. Serban,et al.  Hypervirulent Klebsiella pneumoniae Endogenous Endophthalmitis—A Global Emerging Disease , 2021, Life.

[21]  R. Raman,et al.  Association Between Gut Microbial Abundance and Sight-Threatening Diabetic Retinopathy , 2021, Investigative ophthalmology & visual science.

[22]  K. Nagata,et al.  Gut Microbiome of Indonesian Adults Associated with Obesity and Type 2 Diabetes: A Cross-Sectional Study in an Asian City, Yogyakarta , 2021, Microorganisms.

[23]  Jiangman Zhao,et al.  Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus , 2021, PeerJ.

[24]  Shibo Tang,et al.  Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy , 2021, Frontiers in Cellular and Infection Microbiology.

[25]  H. Kaplan,et al.  Short chain fatty acids inhibit endotoxin-induced uveitis and inflammatory responses of retinal astrocytes. , 2021, Experimental eye research.

[26]  S. Shivaji.  A systematic review of gut microbiome and ocular inflammatory diseases: Are they associated? , 2021, Indian journal of ophthalmology.

[27]  T. Das,et al.  Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy , 2021, Scientific Reports.

[28]  Zhiqiang Wen,et al.  Oscillospira - a candidate for the next-generation probiotics , 2021, Gut microbes.

[29]  T. Kuwahara,et al.  Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health , 2021, Gut microbes.

[30]  N. Papanas,et al.  Diabetic Retinopathy in Patients With Diabetic Foot Ulcer: A Systematic Review , 2020, The international journal of lower extremity wounds.

[31]  K. Yao,et al.  Alterations of the Gut Microbiome and Metabolome in Patients With Proliferative Diabetic Retinopathy , 2020, Frontiers in Microbiology.

[32]  E. Prifti,et al.  From correlation to causality: the case of Subdoligranulum , 2020, Gut microbes.

[33]  R. Petrovska,et al.  Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes , 2020, bioRxiv.

[34]  Cuidan Li,et al.  Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features. , 2020, Parkinsonism & related disorders.

[35]  Chunxue Yang,et al.  Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications , 2020, Redox biology.

[36]  Xiao-long Ye,et al.  Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes , 2020, The Journal of international medical research.

[37]  M. Grant,et al.  The Gut–Eye Axis: Lessons Learned from Murine Models , 2020, Ophthalmology and Therapy.

[38]  J. Duan,et al.  Chinese medicine formula Kai-Xin-San ameliorates depression-like behaviours in chronic unpredictable mild stressed mice by regulating gut microbiota-inflammation-stress system. , 2020, Journal of ethnopharmacology.

[39]  S. Wild,et al.  Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2020, Diabetes research and clinical practice.

[40]  Huan Li,et al.  Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing , 2020, BioMed research international.

[41]  Y. Seo,et al.  Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis , 2020, Applied and Environmental Microbiology.

[42]  R. Ley,et al.  The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health , 2019, BMC Biology.

[43]  Hong Gu,et al.  Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities , 2019, Scientific Reports.

[44]  M. Raizada,et al.  Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice , 2019, Molecular therapy. Methods & clinical development.

[45]  F. Reis,et al.  Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[46]  J. Raes,et al.  Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study , 2019, Nature Medicine.

[47]  J. Chao,et al.  Proline mediates metabolic communication between retinal pigment epithelial cells and the retina , 2019, The Journal of Biological Chemistry.

[48]  D. A. Al Farraj,et al.  Screening and identification of gut anaerobes (Bacteroidetes) from human diabetic stool samples with and without retinopathy in comparison to control subjects. , 2019, Microbial pathogenesis.

[49]  Wei Chen,et al.  Disturbance of trace element and gut microbiota profiles as indicators of autism spectrum disorder: A pilot study of Chinese children☆ , 2019, Environmental research.

[50]  J. Shimizu,et al.  Relative abundance of Megamonas hypermegale and Butyrivibrio species decreased in the intestine and its possible association with the T cell aberration by metabolite alteration in patients with Behcet’s disease (210 characters) , 2019, Clinical Rheumatology.

[51]  T. Kurihara,et al.  Lactobacillus paracasei KW3110 Prevents Blue Light-Induced Inflammation and Degeneration in the Retina , 2018, Nutrients.

[52]  L. Zaharenko,et al.  Association of metformin administration with gut microbiome dysbiosis in healthy volunteers , 2018, PloS one.

[53]  Yujun Jiang,et al.  Administration of Lactobacillus paracasei ameliorates type 2 diabetes in mice. , 2018, Food & function.

[54]  Andrew W. Brooks,et al.  Gut microbiota diversity across ethnicities in the United States , 2018, bioRxiv.

[55]  G. Grunwald,et al.  On the Use of Diversity Measures in Longitudinal Sequencing Studies of Microbial Communities , 2018, Front. Microbiol..

[56]  Yingli Lu,et al.  A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota , 2018, Front. Endocrinol..

[57]  M. Boulton,et al.  Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice , 2018, Diabetes.

[58]  M. Toborek,et al.  Circadian Disruption Changes Gut Microbiome Taxa and Functional Gene Composition , 2018, Front. Microbiol..

[59]  Yeojun Yun,et al.  Rosacea and its association with enteral microbiota in Korean females , 2018, Experimental dermatology.

[60]  R. Isaacson,et al.  Deciphering Diversity Indices for a Better Understanding of Microbial Communities. , 2017, Journal of microbiology and biotechnology.

[61]  H. Lee,et al.  Clinical Effect of IRT-5 Probiotics on Immune Modulation of Autoimmunity or Alloimmunity in the Eye , 2017, Nutrients.

[62]  J. M. Larsen.  The immune response to Prevotella bacteria in chronic inflammatory disease. , 2017, Immunology.

[63]  S. Melgar,et al.  The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces , 2017, Front. Immunol..

[64]  E. Segal,et al.  Involvement of a gut–retina axis in protection against dietary glycemia-induced age-related macular degeneration , 2017, Proceedings of the National Academy of Sciences.

[65]  W. D. de Vos,et al.  Akkermansia muciniphila and its role in regulating host functions. , 2017, Microbial pathogenesis.

[66]  Yueying Liu,et al.  Histone Deacetylase Inhibition Restores Retinal Pigment Epithelium Function in Hyperglycemia , 2016, PloS one.

[67]  H. Taylor,et al.  Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010 , 2016, Diabetes Care.

[68]  C. McPherson,et al.  Microglial M1/M2 polarization and metabolic states , 2016, British journal of pharmacology.

[69]  David A. Stephens,et al.  Linear growth faltering in infants is associated with Acidaminococcus sp. and community-level changes in the gut microbiota , 2015, Microbiome.

[70]  Sang-Mo Kwon,et al.  Tauroursodeoxycholic Acid, a Bile Acid, Promotes Blood Vessel Repair by Recruiting Vasculogenic Progenitor Cells , 2015, Stem cells.

[71]  E. Rakoczy,et al.  Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy in Ins2Akita mice , 2013, British Journal of Ophthalmology.

[72]  Jacques Schrenzel,et al.  Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice , 2011, Diabetes.

[73]  J. Nikkilä,et al.  Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. , 2010, World journal of gastroenterology.

[74]  A. Lambiase,et al.  Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[75]  Renu A. Kowluru,et al.  Oxidative Stress and Diabetic Retinopathy , 2007, Experimental diabetes research.

[76]  S. Rowan,et al.  The Role of Microbiota in Retinal Disease. , 2018, Advances in experimental medicine and biology.

[77]  W. Alexander,et al.  American diabetes association. , 2010, P & T : a peer-reviewed journal for formulary management.

[78]  L. Aiello,et al.  Retinopathy in diabetes. , 2004, Diabetes care.